Rankings
▼
Calendar
ARCT Q1 2023 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$80M
+1431.0% YoY
Gross Profit
$29M
35.5% margin
Operating Income
$15M
18.4% margin
Net Income
$51M
63.2% margin
EPS (Diluted)
$1.87
QoQ Revenue Growth
-49.9%
Cash Flow
Operating Cash Flow
-$36M
Free Cash Flow
-$37M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$471M
Total Liabilities
$142M
Stockholders' Equity
$329M
Cash & Equivalents
$328M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$80M
$5M
+1431.0%
Gross Profit
$29M
-$40M
+171.9%
Operating Income
$15M
-$50M
+129.3%
Net Income
$51M
-$51M
+199.2%
Revenue Segments
Collaboration Revenue
$80M
99%
Grant
$556,000
1%
← FY 2023
All Quarters
Q2 2023 →